{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:58:18Z","timestamp":1785167898794,"version":"3.55.0"},"reference-count":41,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2024,10,2]]},"DOI":"10.1080\/13543776.2024.2403618","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:35:59Z","timestamp":1726115759000},"page":"863-872","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Helicase\u2013primase inhibitors for the treatment of herpes simplex virus infections \u2013 patent evaluation of WO2023\/225162 from Gilead Sciences Inc"],"prefix":"10.1080","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-2774","authenticated-orcid":false,"given":"Christian","family":"Gege","sequence":"first","affiliation":[{"name":"Innovative Molecules GmbH, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Kleymann","sequence":"additional","affiliation":[{"name":"Innovative Molecules GmbH, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"e_1_3_4_2_1","volume-title":"Fields virology","author":"Knipe DM","year":"2013","unstructured":"Knipe DM, Howley PM. Fields virology. 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2013.","edition":"6"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.07.006"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0402-392"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2013.827663"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13948"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13081547"},{"key":"e_1_3_4_8_1","unstructured":"Maruho receives manufacturing and marketing approval for a partial change of the indication and dosage\/administration for anti-herpes virus agent amenalief tab. 200mg for the treatment of recurrent herpes simplex in Japan. [cited 2024 Apr 27]. Available from: www.maruho.co.jp\/english\/information\/20230224.html"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00668"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301150"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.18189"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1241"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00183"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1358"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8668"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16027"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01732-22"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.899"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1138"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2022.2113873"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202100177"},{"key":"e_1_3_4_22_1","unstructured":"Medshine Discovery Inc. Thiazole derivative and applications thereof. WO2018\/127207. 2018."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160405112353"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28073220"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105190"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105733"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fopow.2023.02.013"},{"key":"e_1_3_4_28_1","unstructured":"Bayer AG. Indolinylamide derivatives. WO2000\/076966. 2000."},{"key":"e_1_3_4_29_1","unstructured":"Bayer AG. Thiazolyl amide derivatives.WO2001\/047904. 2001."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr200060g"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081157"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2024.129761"},{"key":"e_1_3_4_33_1","volume-title":"Poster presentation at the 48th Annual International Herpesvirus Workshop, 2024 Jul 13 to Jul 17, Portland","author":"Cho A","unstructured":"Cho A, Nair V, May L, et al. Preclinical characterization of ABI-1179, a potent helicase primase inhibitor for the treatment of recurrent genital herpes. Poster presentation at the 48th Annual International Herpesvirus Workshop, 2024 Jul 13 to Jul 17, Portland. [cited 2024 Aug 8]. Available from: https:\/\/investor.assemblybio.com\/static-files\/8a408cf9-818d-45fd-ae3e-a242a49e35d4"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00233B"},{"key":"e_1_3_4_35_1","unstructured":"Aicuris GmbH & Co. KG. N-[5-(aminosulfonyl)-4-methyl-1 3-thiazol-2-yl]-N-methyl-2-4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate. WO2013\/045479;2013."},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo061486q"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01813"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00910"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060679"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54775"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl067"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz357"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2024.2403618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:44:23Z","timestamp":1727354663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2024.2403618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,2]]}},"alternative-id":["10.1080\/13543776.2024.2403618"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2024.2403618","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}